SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 233 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $228,000 | +1.3% | 6,305 | 0.0% | 0.02% | -11.8% |
| Q4 2022 | $225,000 | +5.1% | 6,305 | -0.2% | 0.02% | -39.3% |
| Q3 2022 | $214,000 | -21.3% | 6,319 | -38.0% | 0.03% | -90.8% |
| Q3 2021 | $272,000 | -13.4% | 10,188 | 0.0% | 0.30% | -14.6% |
| Q2 2021 | $314,000 | +17.6% | 10,188 | 0.0% | 0.36% | +22.3% |
| Q1 2021 | $267,000 | -47.7% | 10,188 | -49.8% | 0.29% | -26.3% |
| Q4 2020 | $511,000 | -9.2% | 20,307 | -24.9% | 0.40% | +4.8% |
| Q3 2020 | $563,000 | -12.3% | 27,039 | -24.2% | 0.38% | -6.0% |
| Q1 2020 | $642,000 | +61.3% | 35,663 | +146.3% | 0.40% | +49.6% |
| Q3 2019 | $398,000 | – | 14,482 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |